IFNG and neoplasm: Using our tumor mouse model with LLC-MUC1 cells, we assessed the tumor-specific (MUC1 versus irrelevant OVA) production of IFN-γ and granzyme B in TdLN cells by enzyme-linked immunospot (ELISPOT) assay.